{"AllianceGenome": "11760", "HGNC": "11760", "MIM": "152310", "_id": "7035", "_version": 2, "accession": {"genomic": ["AB035127.1", "AC007319.2", "AC098485.6", "AH002857.2", "AH002869.2", "AY263365.1", "CH471058.2", "CP068276.2", "NC_000002.12", "NC_060926.1", "NG_029714.2", "S63486.1"], "protein": ["AAA52022.1", "AAD01700.1", "AAH15514.1", "AAO89075.1", "AAY14807.1", "BAD93103.1", "BAG36336.1", "EAX10921.1", "EAX10922.1", "EAX10923.1", "NP_001027452.1", "NP_001305870.1", "NP_001316168.1", "NP_001316169.1", "NP_001316170.1", "NP_006278.1", "P10646.1", "XP_047301573.1", "XP_047301574.1", "XP_047301575.1", "XP_047301576.1", "XP_047301577.1", "XP_047301578.1", "XP_047301579.1", "XP_054199556.1", "XP_054199557.1", "XP_054199558.1", "XP_054199559.1", "XP_054199560.1", "XP_054199561.1"], "rna": ["AB209866.1", "AF021834.1", "AK130306.1", "AK313562.1", "AU136083.1", "BC014332.1", "BC015514.1", "CA418214.1", "DB078397.1", "HY175080.1", "J03225.1", "NM_001032281.4", "NM_001318941.3", "NM_001329239.2", "NM_001329240.2", "NM_001329241.2", "NM_006287.6", "XM_047445617.1", "XM_047445618.1", "XM_047445619.1", "XM_047445620.1", "XM_047445621.1", "XM_047445622.1", "XM_047445623.1", "XM_054343581.1", "XM_054343582.1", "XM_054343583.1", "XM_054343584.1", "XM_054343585.1", "XM_054343586.1"], "translation": [{"protein": "XP_054199561.1", "rna": "XM_054343586.1"}, {"protein": "AAD01700.1", "rna": "AF021834.1"}, {"protein": "NP_006278.1", "rna": "NM_006287.6"}, {"protein": "XP_054199557.1", "rna": "XM_054343582.1"}, {"protein": "AAH15514.1", "rna": "BC015514.1"}, {"protein": "BAG36336.1", "rna": "AK313562.1"}, {"protein": "NP_001316170.1", "rna": "NM_001329241.2"}, {"protein": "AAA52022.1", "rna": "J03225.1"}, {"protein": "XP_047301573.1", "rna": "XM_047445617.1"}, {"protein": "XP_054199559.1", "rna": "XM_054343584.1"}, {"protein": "XP_054199560.1", "rna": "XM_054343585.1"}, {"protein": "XP_054199558.1", "rna": "XM_054343583.1"}, {"protein": "XP_047301576.1", "rna": "XM_047445620.1"}, {"protein": "XP_047301579.1", "rna": "XM_047445623.1"}, {"protein": "NP_001027452.1", "rna": "NM_001032281.4"}, {"protein": "XP_054199556.1", "rna": "XM_054343581.1"}, {"protein": "XP_047301578.1", "rna": "XM_047445622.1"}, {"protein": "XP_047301575.1", "rna": "XM_047445619.1"}, {"protein": "XP_047301577.1", "rna": "XM_047445621.1"}, {"protein": "NP_001316169.1", "rna": "NM_001329240.2"}, {"protein": "NP_001305870.1", "rna": "NM_001318941.3"}, {"protein": "BAD93103.1", "rna": "AB209866.1"}, {"protein": "XP_047301574.1", "rna": "XM_047445618.1"}, {"protein": "NP_001316168.1", "rna": "NM_001329239.2"}]}, "alias": ["EPI", "LACI", "TFI", "TFPI1"], "ensembl": {"gene": "ENSG00000003436", "protein": ["ENSP00000233156", "ENSP00000342306", "ENSP00000376172", "ENSP00000386344", "ENSP00000388159", "ENSP00000394185", "ENSP00000400179", "ENSP00000402954", "ENSP00000408170", "ENSP00000409177"], "transcript": ["ENST00000233156", "ENST00000339091", "ENST00000392365", "ENST00000409676", "ENST00000417013", "ENST00000420747", "ENST00000421427", "ENST00000435414", "ENST00000437725", "ENST00000453013", "ENST00000481132", "ENST00000481389"], "translation": [{"protein": "ENSP00000376172", "rna": "ENST00000392365"}, {"protein": "ENSP00000233156", "rna": "ENST00000233156"}, {"protein": "ENSP00000409177", "rna": "ENST00000435414"}, {"protein": "ENSP00000386344", "rna": "ENST00000409676"}, {"protein": "ENSP00000342306", "rna": "ENST00000339091"}, {"protein": "ENSP00000388159", "rna": "ENST00000437725"}, {"protein": "ENSP00000408170", "rna": "ENST00000421427"}, {"protein": "ENSP00000394185", "rna": "ENST00000453013"}, {"protein": "ENSP00000400179", "rna": "ENST00000417013"}, {"protein": "ENSP00000402954", "rna": "ENST00000420747"}], "type_of_gene": "protein_coding"}, "entrezgene": "7035", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 13.5942981829, "exp_mis": 90.980952961, "exp_syn": 35.6110871402, "lof_z": 2.30898810383512, "mis_z": 1.07588624682014, "mu_lof": 9.59198934101e-07, "mu_mis": 7.91002401511e-06, "mu_syn": 2.93393877557e-06, "n_lof": 5.0, "n_mis": 70.0, "n_syn": 35.0, "p_li": 0.0253229555895134, "p_null": 0.0129671035547326, "p_rec": 0.961709940855754, "syn_z": 0.0634836735908689}, "bp": 915, "cds_end": 188368495, "cds_start": 188331662, "n_exons": 7, "nonpsych": {"exp_lof": 12.163649811, "exp_mis": 82.2060420945, "exp_syn": 32.090969829, "lof_z": 2.58040866746706, "mis_z": 1.23532417849211, "mu_lof": 9.59198934101e-07, "mu_mis": 7.91002401511e-06, "mu_syn": 2.93393877557e-06, "n_lof": 3.0, "n_mis": 60.0, "n_syn": 31.0, "p_li": 0.322036793906924, "p_null": 0.00421377782145945, "p_rec": 0.673749428271616, "syn_z": 0.121250876863496}, "nontcga": {"exp_lof": 12.4930595653, "exp_mis": 83.688787414, "exp_syn": 32.7485077666, "lof_z": 2.09125044266553, "mis_z": 1.01778798949093, "mu_lof": 9.59198934101e-07, "mu_mis": 7.91002401511e-06, "mu_syn": 2.93393877557e-06, "n_lof": 5.0, "n_mis": 65.0, "n_syn": 33.0, "p_li": 0.0174506156485774, "p_null": 0.0220215908697489, "p_rec": 0.960527793481674, "syn_z": -0.0278257757753858}, "transcript": "ENST00000233156.3"}, "exons": [{"cdsend": 187503768, "cdsstart": 187478675, "chr": "2", "position": [[187478578, 187478803], [187484123, 187484216], [187484810, 187484987], [187488336, 187488375], [187496880, 187497078], [187503647, 187503770], [187554199, 187554505]], "strand": -1, "transcript": "NM_001032281", "txend": 187554505, "txstart": 187478578}, {"cdsend": 187503768, "cdsstart": 187478675, "chr": "2", "position": [[187478578, 187478803], [187484123, 187484216], [187484810, 187484987], [187488336, 187488375], [187496880, 187497078], [187503647, 187503770], [187513615, 187513646], [187554199, 187554505]], "strand": -1, "transcript": "NM_001318941", "txend": 187554505, "txstart": 187478578}, {"cdsend": 187503768, "cdsstart": 187466935, "chr": "2", "position": [[187464230, 187467042], [187467752, 187467932], [187484123, 187484216], [187484810, 187484987], [187488336, 187488375], [187496880, 187497078], [187503647, 187503770], [187513615, 187513646], [187529363, 187529485], [187554199, 187554435]], "strand": -1, "transcript": "NM_001329239", "txend": 187554435, "txstart": 187464230}, {"cdsend": 187503768, "cdsstart": 187466935, "chr": "2", "position": [[187464230, 187467042], [187467752, 187467932], [187484123, 187484216], [187484810, 187484987], [187488336, 187488375], [187496880, 187497078], [187503647, 187503770], [187513615, 187513646], [187554199, 187554435]], "strand": -1, "transcript": "NM_001329240", "txend": 187554435, "txstart": 187464230}, {"cdsend": 187503768, "cdsstart": 187466935, "chr": "2", "position": [[187464230, 187467042], [187467752, 187467932], [187484123, 187484216], [187484810, 187484987], [187488336, 187488375], [187496880, 187497078], [187503647, 187503770], [187529363, 187529485], [187554199, 187554435]], "strand": -1, "transcript": "NM_001329241", "txend": 187554435, "txstart": 187464230}, {"cdsend": 187503768, "cdsstart": 187466935, "chr": "2", "position": [[187464230, 187467042], [187467752, 187467932], [187484123, 187484216], [187484810, 187484987], [187488336, 187488375], [187496880, 187497078], [187503647, 187503770], [187554199, 187554435]], "strand": -1, "transcript": "NM_006287", "txend": 187554435, "txstart": 187464230}], "exons_hg19": [{"cdsend": 188368495, "cdsstart": 188343402, "chr": "2", "position": [[188343305, 188343530], [188348850, 188348943], [188349537, 188349714], [188353063, 188353102], [188361607, 188361805], [188368374, 188368497], [188418926, 188419232]], "strand": -1, "transcript": "NM_001032281", "txend": 188419232, "txstart": 188343305}, {"cdsend": 188368495, "cdsstart": 188343402, "chr": "2", "position": [[188343305, 188343530], [188348850, 188348943], [188349537, 188349714], [188353063, 188353102], [188361607, 188361805], [188368374, 188368497], [188378342, 188378373], [188418926, 188419232]], "strand": -1, "transcript": "NM_001318941", "txend": 188419232, "txstart": 188343305}, {"cdsend": 188368495, "cdsstart": 188331662, "chr": "2", "position": [[188328956, 188331769], [188332479, 188332659], [188348850, 188348943], [188349537, 188349714], [188353063, 188353102], [188361607, 188361805], [188368374, 188368497], [188378342, 188378373], [188394090, 188394212], [188418926, 188419162]], "strand": -1, "transcript": "NM_001329239", "txend": 188419162, "txstart": 188328956}, {"cdsend": 188368495, "cdsstart": 188331662, "chr": "2", "position": [[188328956, 188331769], [188332479, 188332659], [188348850, 188348943], [188349537, 188349714], [188353063, 188353102], [188361607, 188361805], [188368374, 188368497], [188378342, 188378373], [188418926, 188419162]], "strand": -1, "transcript": "NM_001329240", "txend": 188419162, "txstart": 188328956}, {"cdsend": 188368495, "cdsstart": 188331662, "chr": "2", "position": [[188328956, 188331769], [188332479, 188332659], [188348850, 188348943], [188349537, 188349714], [188353063, 188353102], [188361607, 188361805], [188368374, 188368497], [188394090, 188394212], [188418926, 188419162]], "strand": -1, "transcript": "NM_001329241", "txend": 188419162, "txstart": 188328956}, {"cdsend": 188368495, "cdsstart": 188331662, "chr": "2", "position": [[188328956, 188331769], [188332479, 188332659], [188348850, 188348943], [188349537, 188349714], [188353063, 188353102], [188361607, 188361805], [188368374, 188368497], [188418926, 188419162]], "strand": -1, "transcript": "NM_006287", "txend": 188419162, "txstart": 188328956}], "generif": [{"pubmed": 11057878, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 11380428, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11460016, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11686353, "text": "The purpose of this review is to outline recent developments in the field related to the structural specificity and biology of TFPI."}, {"pubmed": 11693665, "text": "protease inhibitor of extrinsic coagulation"}, {"pubmed": 11697721, "text": "circadian variations in healthy adults and in subjects with type II diabetes; possible role in increased vascular wall uptake of lipoproteins in diabetic subjects"}, {"pubmed": 11776326, "text": "Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro. Bemiparin enhanced TFPI mRNA in EC under the arterial flow."}, {"pubmed": 11776329, "text": "Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide."}, {"pubmed": 11816723, "text": "The presence of TFPI in human cardiomyocytes is confirmed in ventricle from cardiac soidosis, myocarditis, and AMI patients."}, {"pubmed": 11848461, "text": "The C-terminal domain of TFPI molecule plays a predominant role in the binding to ox-LDL and the binding through the C-terminal part is essential for the ox-LDL-dependent reduction of the anticoagulant activity of TFPI."}, {"pubmed": 11864704, "text": "Plasma levels of the Factor Xa (FXa)-TFPI complex were significantly higher in patients with solid tumours, compared to patients with haematological malignancy and healthy controls."}, {"pubmed": 12028585, "text": "expression of TF and TFPI in human melanoma"}, {"pubmed": 12038800, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12038800, "text": "The tissue factor pathway inhibitor C536T mutation is not associated with the risk of stroke in young adults."}, {"pubmed": 12117418, "text": "MMP-8 cleaves TFPI following Ser(174) in the connecting region between the second and third Kunitz domains 75 M(-1).s(-1)) as well as following Lys(20) within the NH(2)-terminal region. MMP-8 cleavage of TFPI decreases the anticoagulant activity of TFPI"}, {"pubmed": 12193974, "text": "biochemistry, molecular biology, physiology and physiopathology (review)"}, {"pubmed": 12195688, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 12195688, "text": "The CC genotype of the TFPI intron 7 33T-->C polymorphism is an independent protective factor for venous thromboembolism, an effect probably mediated by increased TFPI levels."}, {"pubmed": 12270558, "text": "levels in placenta and myometrium; the concentration seems to be too low to prevent initiation of coagulation"}, {"pubmed": 12408975, "text": "exploration of active components in oxidized low-density lipoprotein that reduce activity of TFPI"}, {"pubmed": 12428111, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 12482841, "text": "The intact C-terminus in GPI-anchored TFPI indicates it is not directly attached to a GPI anchor; rather, it most likely associates with placental endothelium by binding to a GPI-anchored protein."}, {"pubmed": 12540955, "text": "Transfectants expressing equal levels of GPI-linked TFPI or transmembrane TFPI displayed equal anticoagulant potency as assessed by tissue factor-mediated conversion of factor X to factor Xa."}, {"pubmed": 12818258, "text": "High TFPI levels in ovarian follicular fluid underline its physiological importance for maintaining the hypocoagulable state. TFPI in seminal plasma samples of infertile men was reduced, suggesting a correlation between seminal coagulation & fertility."}, {"pubmed": 12871406, "text": "Most aPL recognized full-length TFPI, but not a truncated form of TFPI lacking the C-terminus of the molecule; aPL with high titer anti-TFPI limit TFPI action and are associated with the APS."}, {"pubmed": 12893029, "text": "TFPI of proximal tubular epithelial cells may act against generation of thrombin and tubular fibrin formation induced by tissue factor activation."}, {"pubmed": 14610342, "text": "The TF and TFPI levels depend significantly on the renal function; elevated TF and TFPI levels may be related to thrombosis and atherosclerosis in chronic renal failure patients on peritoneal dialysis"}, {"pubmed": 14656922, "text": "TFPI is involved in the process of thrombus formation in vivo in patients with ACS, which suggests a potential role for TFPI in modulating coronary thrombosis."}, {"pubmed": 15307537, "text": "Immobilized rTFPI slows fibrin deposition on vascular graft material by inhibiting contact pathway and blood borne tissue factor procoagulant arising from either alternatively spliced form of tissue factor or from tissue factor containing microparticles."}, {"pubmed": 15339683, "text": "Immunoglobulin G fractions from subjects with antiphospholipid syndrome have inhibitory activity against tissue factor pathway inhibitor (TFPI)."}, {"pubmed": 15351861, "text": "results suggest that the inhibitory effect of the LMWH tinzaparin on endothelial tube formation is associated with stimulation of the release of TFPI, but not to anti-Factor Xa activity"}, {"pubmed": 15467908, "text": "TF and TFPI mRNA expression, protein levels and activity in trophoblast cells were determined and compared to human umbilical vein endothelial cells"}, {"pubmed": 15604416, "text": "both in humans and mice, there are temporal variations in TFPI activity"}, {"pubmed": 15817451, "text": "caveolin regulates the inhibition by cell-bound TFPI of the active protease production by the extrinsic pathway of coagulation"}, {"pubmed": 15845911, "text": "polymorphisms in and around the TFPI structural gene may be the major genetic determinants of variation in TFPI levels"}, {"pubmed": 15886798, "text": "TFPI may regulate the activity of abundant Tissue Factor in human semen"}, {"pubmed": 15892865, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16113753, "text": "a rapid and economic alternative to the determination of total TFPI antigen by ELISA in plasma samples after heparin application"}, {"pubmed": 16246254, "text": "glycosylation and gene expression induced by stimulation of cells with inflammatory stimuli were compared for the 2 isoforms; Although TFPIalpha comprises 80% of the surface-TFPI, TFPIbeta was responsible for the bulk of the FVIIa/TF inhibitory activity"}, {"pubmed": 16247609, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16270631, "text": "thrombosis patients with low levels of free TFPI are at an increased risk of recurrent venous thromboembolism"}, {"pubmed": 16380494, "text": "changes in circulating tissue factor procoagulant activity (PCA) and other procoagulation proteins in healthy volunteers exposed to 24 h of selective hyperinsulinemia, selective hyperglycemia, or combined hyperinsulinemia and hyperglycemia"}, {"pubmed": 16431924, "text": "Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1"}, {"pubmed": 16488980, "text": "data suggest that protein S deficiency not only increases the risk of thrombosis by impairing the protein C system but also by reducing the ability of TFPI to down-regulate the extrinsic coagulation pathway"}, {"pubmed": 16516912, "text": "TF induction in conjunction with TFPI suppression may be relevant for the increased frequency of myocardial infarction observed in cocaine consumers"}, {"pubmed": 16765424, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16879232, "text": "circadian rhythms affect expression of melatonin and tissue factor pathway inhibitor type"}, {"pubmed": 17003923, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17082321, "text": "platelets TFPI is also released in microvesicles or as a soluble protein"}, {"pubmed": 17180732, "text": "TFPI-1 is expressed by breast cancer and other cancer cell lines maintained in cell culture."}, {"pubmed": 17196206, "text": "in atherosclerotic plaques, a decrease of TFPI contributes to a shift toward increased thrombotic potential in dyslipidemic patients"}, {"pubmed": 17469034, "text": "An inadequate tissue factor pathway inhibitor (TFPI) concentration as a result of elevated tissue factor (TF):tissue factor pathway inhibitor (TFPI) ratio characterizes patients with clinical manifestations of nephrotic syndrome and mild proteinuria."}, {"pubmed": 17702963, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17704111, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17762532, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17762532, "text": "the TFPI -33T->C and -399C->T polymorphisms are significantly associated with venous thrombosis in the presence of other risk factors, especially APS, and may be clinically relevant in patients who are prone to hypercoagulability."}, {"pubmed": 17890962, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17890962, "text": "The TFPI genotype was determined for the T-287C, C-399T, Intron 7 C-33T, and Val264Met (G874A) polymorphisms. The TFPI gene polymorphisms studied were not significantly associated with TFPI levels or activity, nor with the risk of ischaemic stroke."}, {"pubmed": 17931693, "text": "The presence of potent repressor sequences between -1999 and -345 in the TFPI promoter and suggest that the TFPI T-287C promoter polymorphism might be a risk factor for deep vein thrombosis (DVT)."}, {"pubmed": 17951326, "text": "This review article focuses on the major physiological regulator of tissue factor-induced coagulation, tissue factor pathway inhibitor, its expression, anticoagulant function, and its role in normal hemostasis [review]"}, {"pubmed": 18045239, "text": "The association between protein S levels and anticoagulant activity of TFPI"}, {"pubmed": 18067603, "text": "Oral contraceptives with desogestrel, drospirenone or cyproterone acetate caused lower TFPI free antigen levels than levonorgestrel, which may explain the mechanism of OC-related APC resistance & thrombotic risk."}, {"pubmed": 18180609, "text": "Plasma TFPI (tissue factor pathway inhibitor) was signigficantly higher in hyperlipidemic diabetics and those with macrovascular complications"}, {"pubmed": 18217145, "text": "Heparanase facilitates blood coagulation by dissociation of TFPI from the vascular surface shortly after local elevation of heparanase levels, and subsequent induction of TF expression."}, {"pubmed": 18310227, "text": "Levels of intra-alveolar TFPI in adult respiratory distress syndrome are not sufficient to block intra-alveolar TF procoagulant activity due to truncation and inactivation of intra-alveolar TFPI"}, {"pubmed": 18327407, "text": "TFPI influences the angiogenic process via a non-haemostatic pathway, by downregulating the migratory mechanisms of endothelial cells."}, {"pubmed": 18419747, "text": "Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor"}, {"pubmed": 18600090, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18600090, "text": "The significant relationship is not associated with the -33T/C polymorphism, inflammation or endothelial cell perturbation, but is most likely related to release of tissue factor pathway inhibitor from fibrin deposits."}, {"pubmed": 18677291, "text": "Elevated levels of TF and TFPI in patients with peripheral arterial occlusive disease can be independent risk factor for atherosclerotic complications."}, {"pubmed": 18690350, "text": "inhibition of NF-kappaB through stabilization of IkappaB-alpha and activation of Akt phosphorylation may mediate the inhibitory effect of Adp on TF expression"}, {"pubmed": 18695356, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18695356, "text": "The results suggest that genetic variations in TFPI may play an important role in the pathogenesis and risk factors of osteonecrosis of the femoral head."}, {"pubmed": 18977990, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19007969, "text": "TFPI(V264M) displayed increased protein levels and activity compared to TFPI(WT) accompanied by an increase in mRNA levels of TFPI(V264M) due to prolonged stability of TFPI(V264M) mRNA."}, {"pubmed": 19012190, "text": "PPROM is associated with specific changes in the hemostatic/coagulation system."}, {"pubmed": 19016004, "text": "Increased fibrinogen, t-PA, PAI-1 and decreased protein S and TFPI in acromegalic patients may represent a potential hypercoagulable and hypofibrinolytic state, which might augment the risk for atherosclerotic and atherothrombotic complications"}, {"pubmed": 19017259, "text": "analysis the sugar chain structures OF purified full-length plasma TFPI"}, {"pubmed": 19065458, "text": "Tissue factor pathway inhibitor concentrations were elevated in patients with pre-eclampsia."}, {"pubmed": 19132232, "text": "Modulation of endothelial cell tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases."}, {"pubmed": 19169266, "text": "Physiological testosterone concentrations may exert their antithrombotic effects on TFPI expression during inflammation by downregulating NF-kappaB activity."}, {"pubmed": 19238444, "text": "HuGE review of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19244162, "text": "Protein S bound TFPI efficiently, independently of PROS1 Zn(2+) content"}, {"pubmed": 19277407, "text": "The study suggests that low testosterone levels in elderly men is associated with low plasma free TFPI and subsequent shortened initiation phase of tissue factor -induced coagulation."}, {"pubmed": 19350127, "text": "Tissue pathway factor inhibitor (TFPI) activity is elevated in pregnant patients at 20 weeks gestation who subsequently develop preeclampsia."}, {"pubmed": 19401682, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19411818, "text": "decreased TFPI levels in patients with Cushing's syndrome represent a potential hypercoagulable and hypofibrinolytic state, which might augment the risk for atherosclerotic and atherothrombotic complications"}, {"pubmed": 19467658, "text": "TFPI levels were associated with carotid artery disease and coronary artery calcium."}, {"pubmed": 19630792, "text": "TFPI-activity depends on protein S, and TFPI and protein S are major regulators of thrombin generation [REVIEW]"}, {"pubmed": 19631649, "text": "Results suggest that CRP may promote coagulation by enhancing the expression and activity of TF and reducing that of TFPI by activating NF-kappaB and extracellular signal-regulated kinases 1 and 2 via FcgammaR II."}, {"pubmed": 19689998, "text": "Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy."}, {"pubmed": 19859836, "text": "In patients with Graves' disease, serum-free T levels were inversely correlated with TFPI Ag levels."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20002538, "text": "Full-length TFPI binds to protein S in plasma and is reduced in genetic and acquired protein S deficiency."}, {"pubmed": 20034913, "text": "Significant differences were found in plasma TFPI-1 and D-dimer between the patients (on the second and third posttrauma days) and the control group."}, {"pubmed": 20062932, "text": "TFPI mRNA/protein is present in colon and breast cancer cells, suggesting that it may play a role in cancer biology. The presence of TFPI in association with breast cancer cells localised in regional lymph nodes may indicate its role in lymphatic spread."}, {"pubmed": 20088940, "text": "Report thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals."}, {"pubmed": 20128871, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20140262, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20431849, "text": "Low TFPI levels are a prospective risk factor for venous thromboembolism."}, {"pubmed": 20442653, "text": "Testosterone at a physiological concentration may help to prevent thrombosis development by stimulating TFPI expression in HUVECs, partly through the ERK1/2 and JNK MAPK pathway."}, {"pubmed": 20444258, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20453636, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20492471, "text": "PS that retains native Zn(2)(+) also retains anticoagulant functions independently of APC and TFPI"}, {"pubmed": 20519147, "text": "the -287C and the -33C alleles of TFPI can be associated with lowered risk of thrombosis."}, {"pubmed": 20523161, "text": "The Asn221Ser mutation occurring in the TFPI-beta form was associated with the total TFPI level, but not a risk for deep vein thrombosis."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20978710, "text": "low free TFPI at distance from pregnancy appears to be a strong indicator of gestational vascular complications risk"}, {"pubmed": 21029363, "text": "Therapeutic rh-TFPI attenuates coagulation, inflammation and bacterial growth during pneumococcal pneumonia."}, {"pubmed": 21132373, "text": "The current study was designed to address the role TFPI gene plays in the cell cycle of human vascular smooth muscle cells."}, {"pubmed": 21293010, "text": "In postmenopausal women, free TFPI increases as vascular wall function deteriorates and pulse pressure increases. Vascular smooth muscle cells synthesize TFPI in response to cyclic stress in vitro."}, {"pubmed": 21344386, "text": "The increase in TF protein levels by progesterone is not coupled to the progesterone increase in TF-mediated coagulation. In epithelial derived cancer cells, TFPI can inhibit coagulation without causing the relocalization of TF."}, {"pubmed": 21474669, "text": "an unexpected procoagulant role of the protein C pathway that may have important implications for the regulation of TF- and TFPI-dependent biologic responses and for fine tuning of the hemostatic balance in the vascular system."}, {"pubmed": 21555871, "text": "The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease."}, {"pubmed": 21664032, "text": "level of TFPI antigen lower in cord blood plasma than in maternal blood plasma"}, {"pubmed": 21849050, "text": "Investigated the effects of TFPI on self-sustained growth and motility of these cells, and of another invasive breast cancer cell type (MDA-MB-231). Downregulation of TFPI was associated with increased self-sustained cell growth."}, {"pubmed": 21868574, "text": "This study confirms ADTRP expression and colocalization with TFPI and caveolin-1 in endothelial cell."}, {"pubmed": 21895962, "text": "TFPI/protein S activity and APC sensitivity are increased in women with MI"}, {"pubmed": 21979881, "text": "Pregnancy decreases TFPI and protein S levels, attenuating the function of the TFPI and protein C systems, resulting in elevated thrombin generation and increased activated protein C resistance in pregnancy with a history of preeclampsia."}, {"pubmed": 22144186, "text": "TFPIbeta is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes."}, {"pubmed": 22178066, "text": "Our findings indicate that circulating monocytes of asymptomatic individuals with echolucent lipid-rich carotid atherosclerosis express an imbalance between TF and TFPI."}, {"pubmed": 22363056, "text": "Procoagulant changes in TFPI or nAPCsr do not modify the increased ischemic stroke risk due to postmenopausal hormone therapy."}, {"pubmed": 22449009, "text": "Report tissue factor pathway inhibitor as an efficient inhibitor of factor VII-activating protease."}, {"pubmed": 22461171, "text": "Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor."}, {"pubmed": 22627666, "text": "The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa"}, {"pubmed": 22632032, "text": "TFPI inhibitor BAX499 improved ex vivo clotting parameters in blood and plasma from patients with hemophilia A and B with different severity of disease, and also in a patient with acquired hemophilia."}, {"pubmed": 22658294, "text": "These results suggest that BAX499 may be a useful addition to the armamentarium of bypassing agents to control bleeding in hemophilic patients with inhibitors."}, {"pubmed": 22749962, "text": "TFPI gene variation and ischemic stroke."}, {"pubmed": 22836130, "text": "The study reports the association of TFPI -33 T > C polymorphism with cerebral venous thrombosis and shows that the mutation is protective in Indian population."}, {"pubmed": 22900482, "text": "Letter: impaired TFPI function in patients with previous unprovoked DVT is associated with a marked increased risk of recurrent VTE."}, {"pubmed": 22918506, "text": "effect of antithrombin (SERPINC1), protein C (PROC), thrombomodulin (THBD) and tissue factor pathway inhibitor (TFPI) single nucleotide polymorphisms (SNPs) on the risk of recurrent pregnancy loss"}, {"pubmed": 22932941, "text": "Overexpression of human TFPI affected the apoptotic activity through a process independent of caspase-3, and was also able to increase the activation of the NF- kappaB pathway."}, {"pubmed": 22985614, "text": "Data suggest that children with hypothyroidism exhibit decreased TFPI (tissue factor pathway inhibitor), decreased thrombomodulin, and increased TAFI (thrombin-activatable fibrinolysis inhibitor) in plasma."}, {"pubmed": 23038262, "text": "PAK1 negatively regulates the expression of TFPI and additionally contributes to increased TF activity."}, {"pubmed": 23071754, "text": "Overexpression of either TFPI isoform significantly affects the expression of genes involved in cell development and immune response."}, {"pubmed": 23074276, "text": "TFPI Kunitz domain 3 residue Glu226 is essential for TFPI enhancement by protein S."}, {"pubmed": 23327927, "text": "We present a novel role for TFPI and GPC3 in regulating hematopoietic stem cell homing as well as retention in the bone marrow."}, {"pubmed": 23348798, "text": "tissue factor pathway inhibitor has a role in coagulation in hemostasis, particularly when FVIII is missing"}, {"pubmed": 23374966, "text": "TFPI inhibited MCP-3 expression induced by TNF-alpha; this effect may be propagated through the NF-kappaB/IkappaB-alpha pathway."}, {"pubmed": 23407778, "text": "The effect of oral contraceptives on TFPI and PS is a possible explanation for the increased risk of venous thrombosis associated with oral contraceptives."}, {"pubmed": 23524311, "text": "The expression of tissue factor and tissue factor pathway inhibitor in prostate cancer cells themselves is unlikely to be the source of hypercoagulability in patients, but might precipitate chains of events that would produce such an effect."}, {"pubmed": 23530052, "text": "structural features within residues of the 39-loop contribute to the resistance of FIXa to inhibition by plasma inhibitors ZPI and TFPI."}, {"pubmed": 23841464, "text": "Both the protein S and the TFPI ratios were increased in patients with cirrhosis compared to controls."}, {"pubmed": 23979162, "text": "The east Texas bleeding disorder-associated F5(A2440G) mutations leads to the formation of the TFPIalpha:FV-short complex, which inhibits activation and propagation of coagulation."}, {"pubmed": 24094893, "text": "TFPI mRNA expression was increased in clear cell carcinoma (P<0.01)."}, {"pubmed": 24127605, "text": "Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation."}, {"pubmed": 24226152, "text": "genetic polymorphism affects endogenous thrombin potential among FV Leiden carriers"}, {"pubmed": 24233486, "text": "Demonstrate a 5' untranslated region alternative splicing event that alters translation of TFPI isoforms produced via independent 3' splicing events within the same gene."}, {"pubmed": 24233490, "text": "PS exerts anticoagulant cofactor activity with TFPIalpha from any physiological pool, likely by localizing TFPIalpha to membrane surfaces, stabilizing its interaction with membrane-bound FXa, and slowing thrombin generation."}, {"pubmed": 24275667, "text": "Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI)."}, {"pubmed": 24448154, "text": "Neither genetic polymorphisms nor the plasma levels of TFPI seem to act as direct risk factors for venous thromboembolism."}, {"pubmed": 24461489, "text": "TFPI is an early biomarker in myocardial infarct and may explain the final infarct size."}, {"pubmed": 24620349, "text": "Studies indicate differential expression of tissue factor pathway inhibitor isoforms TFPIalpha and TFPIbeta in platelets and endothelial cells."}, {"pubmed": 24716194, "text": "Most capillary endothelial cells of the cholecystitis group presented weak expression for TFPI."}, {"pubmed": 24740810, "text": "Data indicate that the protein S sex hormone-binding globulin (SHBG)-like domain was important for binding and enhancement of tissue factor pathway inhibitor (TFPI)."}, {"pubmed": 24966616, "text": "Colon TFPI levels are increased in ulcerative colitis."}, {"pubmed": 25163770, "text": "Describe inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs."}, {"pubmed": 25303460, "text": "Thrombin decreases TFPI expression in human pleural mesothelial cells."}, {"pubmed": 25348176, "text": "Direct inhibition of FXa by TFPIalpha inhibits thrombin generation and contributes to the downregulation of coagulation."}, {"pubmed": 25359215, "text": "TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2."}, {"pubmed": 25617766, "text": "Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells"}, {"pubmed": 25712553, "text": "A significant degradation of TFPI was induced by ROS exposure, resulting in a decreased ability to bind FXa. ROS induce a procoagulant state in endothelial cells by altering TFPI structure, resulting in inhibition of TFPI binding to Factor Xa"}, {"pubmed": 25864889, "text": "TNFalpha and Stx-1 compared to TNFalpha alone leads to an increase in procoagulant TF on endothelial cells, which is explained by a significant decrease in TFPI not co-localized with TF and not to an increase in TF not co-localized with TFPI"}, {"pubmed": 25879386, "text": "rs5940 and rs7586970 moderate TFPI plasma levels and are candidate risk factors for thrombosis, but the regulation of TFPI plasma levels involves genetic factors beyond the TFPI gene. Review."}, {"pubmed": 25882602, "text": "This study indicates that genetic and phenotypic variation of both TFPIalpha and TFPIbeta, more than TF, are markers of cancer progression."}, {"pubmed": 26163243, "text": "coagulation system, TFPI play an important role in the pathogenesis of CRSwNP."}, {"pubmed": 26233570, "text": "Association between genetic polymorphisms and deep vein thrombosis in a Chinese population."}, {"pubmed": 26377606, "text": "the main finding of the current study is the remarkable elevation in the plasma levels of both total and free TFPI in septic patients at baseline. The levels of both forms of the inhibitor remained elevated throughout the first 24 h with further elevation after enoxaparin administration."}, {"pubmed": 26496276, "text": "Tissue factor pathway inhibitor-2 gene polymorphisms were associated with coronary atherosclerosis in the Chinese population"}, {"pubmed": 26598923, "text": "HIF-1alpha is involved in the transcriptional regulation of the TFPI gene, and suggests that a hypoxic microenvironment inside a breast tumor may induce a procoagulant state in breast cancer patients."}, {"pubmed": 26681757, "text": "Tissue factor pathway inhibitor activity and APC resistance are related to coronary heart disease risk in women, but may not explain the increased CHD risk due to estrogen plus progestin therapy."}, {"pubmed": 26765308, "text": "Circulating FVII, FVIIa and TFPI were significantly elevated in women with severe preeclampsia in the absence of comparable changes in plasma TF levels."}, {"pubmed": 26826018, "text": "secreted TFPI, cell-surface associated TFPI, and intracellular TFPI, and seemed to be dependent upon hypoxia inducible factor-2alpha (HIF-2alpha). An increase in FXa activity was also observed on the endothelial cell surface, reflecting an increase in pro-thrombotic potential of the cells."}, {"pubmed": 26945263, "text": "a concentration of tissue factor pathway inhibitor was significantly lower in patients with essential thrombocythemia with JAK2 V617F mutation as compared with patients without the mutation"}, {"pubmed": 26968713, "text": "Tissue Factor Pathway Inhibitor Gene Polymorphism is associated with response to therapy in Colorectal Cancer."}, {"pubmed": 26999003, "text": "miR-27a/b and miR-494 regulate TFPIalpha expression; there may be a role of these miRNAs in the estrogen-mediated downregulation of TFPIalpha"}, {"pubmed": 26999742, "text": "ERalpha can interact with all three ERE half-sites in the TFPI 5'-flanking region."}, {"pubmed": 27207418, "text": "This review presents a comprehensive understanding of TFPI structure, biochemistry, and cellular expression which is necessary to understand how it modulates bleeding in hemophilia and the physiological impact of therapeutic agents targeting TFPI."}, {"pubmed": 27801970, "text": "Cleavage of FV at Arg(1545) , which abolishes the anticoagulant properties of FV and commits FV to the procoagulant pathway, is inhibited by binding of the TFPIalpha C-terminus to the FV acidic region"}, {"pubmed": 28211163, "text": "Developed functional protein S assays that measure both the activated protein C- and TFPI-cofactor activities of protein S in plasma, which are hardly if at all affected by the FV Leiden mutation."}, {"pubmed": 28246607, "text": "TFPI-1 was a valuable predictor of deep venous thrombosis and tumor metastasis in non-small cell lung cancer patients."}, {"pubmed": 28328938, "text": "Among high-risk women, the tissue factor pathway inhibitor activity of patients with gestational vascular complications is higher than that in other patients. Hence, these markers could augment a screening strategy."}, {"pubmed": 28393401, "text": "Among the various candidate genes involved in acute rejection, CD47 inhibits monocyte/macrophage-mediated phagocytosis by identifying the CD47 signal regulatory protein alpha (SIRP-alpha) as self/non-self. Tissue factor pathway inhibitor (TFPI) is involved in the regulation of the coagulation pathway and is able to bind to another ligand of CD47, thrombospondin-1 (TSP-1)."}, {"pubmed": 28421636, "text": "TFPI single nucleotide polymorphism is associated with venous thromboembolism."}, {"pubmed": 28482260, "text": "These data indicate that both isoforms of TFPI are present in advanced plaques and that anti-inflammatory M2 macrophages may be a potential source of TFPI."}, {"pubmed": 28521572, "text": "plasma level not different between pre-eclampsia and normal pregnancy"}, {"pubmed": 28569919, "text": "Patients with early onset preeclampsia are characterised by an attenuated coagulation response characterised by reduced thrombin generation stimulated by low-dose TF and elevated plasma TFPI activity."}, {"pubmed": 28712870, "text": "The results show that cholesterol crystals induce TFPI and cytokine expression in M2-polarized macrophages through activation of the endoplasmic reticulum stress pathway and that TFPI has a protective effect against TNF-alpha and IL-6 mediated inflammation."}, {"pubmed": 28716011, "text": "Genetic variations of the TFPI genes seem to be related with coronary artery disease, which likely cooperate with metabolic risk factor (diabetes mellitus) and play critical roles in the pathogenesis of coronary artery disease in Han Chinese."}, {"pubmed": 28749986, "text": "The aim of this study was to evaluate the concentration of TF and its inhibitor TFPI in blood plasma, the impact of traditional and non-traditional cardiovascular risk factors on their concentration and the impact of both markers of haemostasis on the severity of subclinical atherosclerosis."}, {"pubmed": 28894953, "text": "For the first time, we show that a TFPI variant is significantly associated with fibrinogen levels and risk of coronary artery disease."}, {"pubmed": 28983056, "text": "Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma"}, {"pubmed": 29452445, "text": "under flow, TFPI-alpha is capable to antagonize fibrin formation in a manner dependent on and restricted by local TF/factor VIIa and factor Xa activities"}, {"pubmed": 29864781, "text": "FV (and particularly its FV2 isoform) contributes to the TFPIalpha-dependent down-regulation of thrombin generation in plasma triggered with low TF."}, {"pubmed": 30366247, "text": "Thrombin generation increases between the up- and downregulation phases of In Vitro Fertilization (IVF). No correlation between thrombin generation and TFPI was shown during IVF."}, {"pubmed": 30439766, "text": "REVIEW of function of TFPI and effects of modification, pharmacological agents, and proteases on TFPI function."}, {"pubmed": 30695687, "text": "the mechanism in inhibiting the development of atherosclerosis and clinical effects of TFPI"}, {"pubmed": 30861202, "text": "Transcription factor FOXP3: A repressor of the TFPI gene?"}, {"pubmed": 30896671, "text": "Meta-analysis suggested that different TFPI polymorphisms may have different associations with venous thrombosis. TFPI rs8176592 polymorphism may increase the risk of venous thrombosis, especially in Asians and hospital-based patients. The TFPI rs10931292 polymorphism may increase the venous thrombosis risk for both non-Asians and population-based patients"}, {"pubmed": 30952698, "text": "Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors."}, {"pubmed": 32445923, "text": "Data identify POU1F1 as a transcription factor that regulates TFPI transcription in response to ADTRP, and link POU1F1 variants to risk of CAD for the first time."}, {"pubmed": 32877953, "text": "Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample."}, {"pubmed": 33465109, "text": "A rare coding mutation in the MAST2 gene causes venous thrombosis in a French family with unexplained thrombophilia: The Breizh MAST2 Arg89Gln variant."}, {"pubmed": 33496735, "text": "Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency."}, {"pubmed": 33529886, "text": "Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsia."}, {"pubmed": 33827254, "text": "Major Reservoir for Heparin-Releasable TFPIalpha (Tissue Factor Pathway Inhibitor alpha) Is Extracellular Matrix."}, {"pubmed": 34828331, "text": "Single Nucleotide Polymorphisms from CSF2, FLT1, TFPI and TLR9 Genes Are Associated with Prelabor Rupture of Membranes."}, {"pubmed": 34876522, "text": "Intersection of regulatory pathways controlling hemostasis and hemochorial placentation."}, {"pubmed": 35234315, "text": "Effects of human TFPI and CD47 expression and selectin and integrin inhibition during GalTKO.hCD46 pig lung perfusion with human blood."}, {"pubmed": 35973191, "text": "Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency."}, {"pubmed": 37030150, "text": "Endothelial-dependent S-Sulfhydration of tissue factor pathway inhibitor regulates blood coagulation."}, {"pubmed": 37660436, "text": "Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation."}, {"pubmed": 38501385, "text": "The RNA-binding protein sorbin and SH3 domain-containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor."}], "genomic_pos": {"chr": "2", "end": 187565760, "ensemblgene": "ENSG00000003436", "start": 187464230, "strand": -1}, "genomic_pos_hg19": {"chr": "2", "end": 188430487, "start": 188328957, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0007596", "qualifier": "involved_in", "term": "blood coagulation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030195", "pubmed": 21868574, "qualifier": "involved_in", "term": "negative regulation of blood coagulation"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0071383", "pubmed": 21868574, "qualifier": "involved_in", "term": "cellular response to steroid hormone stimulus"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 19065458, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005783", "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005901", "pubmed": 21868574, "qualifier": "located_in", "term": "caveola"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0009986", "pubmed": 19581412, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009986", "pubmed": 21868574, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098552", "qualifier": "located_in", "term": "side of membrane"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0004866", "pubmed": 9252393, "qualifier": "enables", "term": "endopeptidase inhibitor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004867", "qualifier": "enables", "term": "serine-type endopeptidase inhibitor activity"}]}, "homologene": {"genes": [[7955, 359833], [9031, 423989], [9544, 613026], [9598, 470603], [9606, 7035], [9913, 508763], [10090, 21788], [10116, 29436]], "id": 4579}, "interpro": [{"desc": "Pancreatic trypsin inhibitor Kunitz domain", "id": "IPR002223", "short_desc": "Kunitz_BPTI"}, {"desc": "Proteinase inhibitor I2, Kunitz, conserved site", "id": "IPR020901", "short_desc": "Prtase_inh_Kunz-CS"}, {"desc": "Pancreatic trypsin inhibitor Kunitz domain superfamily", "id": "IPR036880", "short_desc": "Kunitz_BPTI_sf"}, {"desc": "Tissue factor pathway inhibitor-like", "id": "IPR008296", "short_desc": "TFPI-like"}], "ipi": ["IPI00021834", "IPI00218184", "IPI00555718", "IPI00916075", "IPI00916882", "IPI00917029", "IPI00917813", "IPI00917946"], "map_location": "2q32.1", "name": "tissue factor pathway inhibitor", "other_names": ["anti-convertin", "extrinsic pathway inhibitor", "tissue factor pathway inhibitor", "tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)"], "pantherdb": {"HGNC": "11760", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1095418", "ortholog_type": "LDO", "panther_family": "PTHR10083", "taxid": 10090, "uniprot_kb": "O54819"}, {"RGD": "61914", "ortholog_type": "LDO", "panther_family": "PTHR10083", "taxid": 10116, "uniprot_kb": "Q02445"}, {"Ensembl": "ENSGALG00000002594", "ortholog_type": "LDO", "panther_family": "PTHR10083", "taxid": 9031, "uniprot_kb": "E1BUM2"}, {"ZFIN": "ZDB-GENE-131120-176", "ortholog_type": "LDO", "panther_family": "PTHR10083", "taxid": 7955, "uniprot_kb": "E7EYN3"}, {"WormBase": "WBGene00020017", "ortholog_type": "LDO", "panther_family": "PTHR10083", "taxid": 6239, "uniprot_kb": "O16701"}], "uniprot_kb": "P10646"}, "pathway": {"biocarta": {"id": "extrinsicpathway", "name": "extrinsic prothrombin activation pathway"}, "kegg": {"id": "hsa04610", "name": "Complement and coagulation cascades - Homo sapiens (human)"}, "pid": {"id": "syndecan_4_pathway", "name": "Syndecan-4-mediated signaling events"}, "reactome": [{"id": "R-HSA-109582", "name": "Hemostasis"}, {"id": "R-HSA-140834", "name": "Extrinsic Pathway of Fibrin Clot Formation"}, {"id": "R-HSA-140877", "name": "Formation of Fibrin Clot (Clotting Cascade)"}], "wikipathways": [{"id": "WP1984", "name": "Integrated breast cancer pathway"}, {"id": "WP558", "name": "Complement and Coagulation Cascades"}]}, "pdb": ["1ADZ", "1IRH", "1TFX", "4BQD", "4DTG", "5NMV", "6BX8", "7V1N"], "pfam": "PF00014", "pharmgkb": "PA36475", "pharos": {"target_id": 13976, "tdl": "Tchem"}, "pir": "A23712", "prosite": "PS50279", "reagent": {"CM-LibrX-no-seq": [{"id": "GNF325586", "relationship": "is"}, {"id": "GNF325587", "relationship": "is"}, {"id": "GNF325588", "relationship": "is"}], "CondMedia_CM_LibrAB": {"id": "GNF293194", "relationship": "is"}, "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF168593", "relationship": "is"}, {"id": "GNF179499", "relationship": "is"}, {"id": "GNF190405", "relationship": "is"}, {"id": "GNF201311", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF157152", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF047773", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF014491", "relationship": "is"}, "MasterSecretomicsList": [{"id": "GNF330939", "relationship": "is"}, {"id": "GNF332484", "relationship": "is"}, {"id": "GNF334260", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": [{"id": "GNF337015", "relationship": "is"}, {"id": "GNF338919", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF105077", "relationship": "is"}, {"id": "GNF144724", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1", "NG_029714.2"], "protein": ["NP_001027452.1", "NP_001305870.1", "NP_001316168.1", "NP_001316169.1", "NP_001316170.1", "NP_006278.1", "XP_047301573.1", "XP_047301574.1", "XP_047301575.1", "XP_047301576.1", "XP_047301577.1", "XP_047301578.1", "XP_047301579.1", "XP_054199556.1", "XP_054199557.1", "XP_054199558.1", "XP_054199559.1", "XP_054199560.1", "XP_054199561.1"], "rna": ["NM_001032281.4", "NM_001318941.3", "NM_001329239.2", "NM_001329240.2", "NM_001329241.2", "NM_006287.6", "XM_047445617.1", "XM_047445618.1", "XM_047445619.1", "XM_047445620.1", "XM_047445621.1", "XM_047445622.1", "XM_047445623.1", "XM_054343581.1", "XM_054343582.1", "XM_054343583.1", "XM_054343584.1", "XM_054343585.1", "XM_054343586.1"], "translation": [{"protein": "XP_054199561.1", "rna": "XM_054343586.1"}, {"protein": "NP_006278.1", "rna": "NM_006287.6"}, {"protein": "XP_054199557.1", "rna": "XM_054343582.1"}, {"protein": "NP_001316170.1", "rna": "NM_001329241.2"}, {"protein": "XP_047301573.1", "rna": "XM_047445617.1"}, {"protein": "XP_054199559.1", "rna": "XM_054343584.1"}, {"protein": "XP_054199560.1", "rna": "XM_054343585.1"}, {"protein": "XP_054199558.1", "rna": "XM_054343583.1"}, {"protein": "XP_047301576.1", "rna": "XM_047445620.1"}, {"protein": "XP_047301579.1", "rna": "XM_047445623.1"}, {"protein": "NP_001027452.1", "rna": "NM_001032281.4"}, {"protein": "XP_054199556.1", "rna": "XM_054343581.1"}, {"protein": "XP_047301578.1", "rna": "XM_047445622.1"}, {"protein": "XP_047301575.1", "rna": "XM_047445619.1"}, {"protein": "XP_047301577.1", "rna": "XM_047445621.1"}, {"protein": "NP_001316169.1", "rna": "NM_001329240.2"}, {"protein": "NP_001305870.1", "rna": "NM_001318941.3"}, {"protein": "XP_047301574.1", "rna": "XM_047445618.1"}, {"protein": "NP_001316168.1", "rna": "NM_001329239.2"}]}, "reporter": {"HG-U133_Plus_2": ["209676_at", "210664_s_at", "210665_at", "213258_at", "214378_at"], "HG-U95Av2": "40767_at", "HTA-2_0": ["TC02002606.hg.1", "TC02004744.hg.1"], "HuEx-1_0": ["2591421", "2591482", "4019695"], "HuGene-1_1": "8057599", "HuGene-2_1": "16906308"}, "summary": "This gene encodes a Kunitz-type serine protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. Inhibition of the encoded protein restores hemostasis in animal models of hemophilia. This gene encodes multiple protein isoforms that differ in their inhibitory activity, specificity and cellular localization. [provided by RefSeq, Jul 2016].", "symbol": "TFPI", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1420705"}, "unigene": "Hs.516578", "uniprot": {"Swiss-Prot": "P10646", "TrEMBL": ["C9J103", "C9JQ14", "C9JP39", "C9JT76", "C9JKV3"]}, "wikipedia": {"url_stub": "Tissue factor pathway inhibitor"}}